SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid renewed confidence in its turnaround, fueled by a strong earnings report and positive outlook on AI and chip demand. Community members are discussing the potential for significant gains and Intel's strategic positioning in the tech sector. Bullish sentiment seems to be rising, with some suggesting the stock has substantial room to grow.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending alongside other meme coins like DOGE and PEPE, with community members expressing both frustration and continued conviction. Some investors are looking to SHIB as a potential solution for larger economic issues, while others are pointing to new Solana-based meme coins as having greater potential. Discussions include longing, burning, and speculation around future price movements.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending as investors digest recent earnings and future production forecasts, with some expressing concerns about warnings of lower production in 2026 despite a recent EPS jump. The community is actively debating the stock's reaction to earnings, potential market manipulation, and the CEO's performance during the earnings call. Broader discussions include gold's potential price movements and its impact on mining stocks.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community expresses strong bullish sentiment and highlights its resilience. Conversations mention the importance of community support and long-term holding, with some drawing comparisons to other meme coins like $DOGE and $SHIB. The focus remains on the strength and potential of the WAGMI community.

Pump.fun

$PUMP is trending amid discussions about its connection to the $SOL ecosystem and the $WAGMI community, with some highlighting its potential for growth. Community members are actively sharing positive sentiments, emphasizing long-term holding, and referencing a 'manifesto'. Others are looking at recent price action to determine if the floor has been found.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending amid Bitcoin's surge to new all-time highs, driven by supportive regulations and institutional demand, especially JPMorgan raising its year-end price target. The community is actively discussing whether this rally will trigger an altcoin season and the potential for significant liquidations with Bitcoin ETFs trading volumes surpassing billions. Some investors are also debating Bitcoin's role as a safe haven asset compared to gold, along with the impact of potential market manipulations.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

INBX is trending due to positive news regarding a potential accelerated FDA approval pathway for INBRX-101, driving significant pre-market gains. The community is actively discussing potential price targets, short positions, and whether the news justifies the stock's surge. Some traders are expressing caution, suggesting the move may be a pump and dump, while others believe there's more room for growth based on analyst upgrades.

$BALLIN is the perfect meme for everyone showing up every single day.  To be BALLIN, you gotta B-All-In.  The meaning to B All In doesn't only apply to the funds you invest.  It's about dedication.   The countless hours of research.   The endless raiding and working for your bags.  Not knowing how to quit while everyone is telling you you're wrong.  It's about believing in something.  Keep $BALLIN

B All In

$BALLIN is gaining attention, particularly within the Phantom Wallet community, with many highlighting its potential for significant gains and associating it with a luxury lifestyle. The community is actively encouraging others to buy and 'join the movement,' while also referencing its bullish chart patterns.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses its potential, historical performance, and future price targets, with some suggesting it's primed for a significant move. Conversations also revolve around its association with Elon Musk and comparisons to other meme coins like Shiba Inu. Some traders are speculating on potential trading strategies, while others express frustration with its price action.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending due to an analyst downgrade from Stifel, citing concerns over shrinking ad appeal, poor monetization, and outdated ad tech, sparking debate among investors about the company's short-term versus long-term potential. Some community members believe the downgrade presents a buying opportunity, while others point to high sell volume and potential buyout rumors, suggesting a significant move may be on the horizon ahead of earnings. Discussions also revolve around Snap's upcoming Lens Fest event and potential catalysts related to augmented reality and AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know

AbbVie (ABBV) concluded the recent trading session at $228.68, signifying a -1.17% move from its prior day's close.

AbbVie Up More Than 30% in 6 Months: How to Play the Stock

AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

This 3 Stocks Portfolio Provides Monthly Income

Who doesn't like payday? Investors can structure a portfolio that provides monthly income with this combination of three stocks. 

Top Stock Reports for Apple, Meta Platforms & JPMorgan

Apple's Services surge, Meta's AI push, and JPMorgan's strong capital markets results headline today's top stock research picks.

Final Trades: Abbvie, Qualcomm, Aptiv, and Palo Alto Networks

The Investment Committee give you their top stocks to watch for the second half...

The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients

The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients The Confidence Project by BOTOX Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients...

Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings

ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's decline.

Novo Nordisk AS (NVO) on Friday hired U.S. pharmaceutical industry veteran Greg Miley as its senior vice president of corporate affairs, amid growing pressure from President Donald Trump over the pricing of its drugs in the United States.“This opportunity comes at a pivotal moment for the company, and I am eager to get started and contribute to our mission of improving the lives of people living with chronic diseases,” Miley said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.linkedin.com/posts/gregmiley_danish-newbeginnings-novonordisk-activity-7384944872182636544-moHn">post</a> on LinkedIn, adding that he will be joining Novo Nordisk next month.Miley currently serves as senior vice president of government affairs at U.S. pharmaceutical company AbbVie Inc. (ABBV).<figure class="image"><img style="aspect-ratio:746/506;" src="https://news.stocktwits-cdn.com/Greg_Miley_post_jpg_3d08d2aaa2.webp" alt="Greg Miley's post on LinkedIn" width="746" height="506"><figcaption>Greg Miley's post on LinkedIn | Greg Miley/LinkedIn</figcaption></figure>Miley’s appointment comes after President Trump&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-novo-nordisk-stocks-fall-after-hours-trump-pledges-swift-price-cuts-for-fat-loss-drugs/ch6rwjbR3Fa">said</a> during a White House event on Thursday that the prices of Novo Nordisk’s diabetes drug, Ozempic, will be “much lower.” He added that under his administration’s plans, the prices of Ozempic could be brought down to just $150 a month, from its current list price of $1,000 for a month’s supply.<a href="https://stocktwits.com/symbol/NVO">Novo Nordisk shares</a> were down more than 4% in Friday morning’s trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory at the time of writing.Novo currently offers a month’s supply of Ozempic at $499 a month for uninsured or self-paying customers, while insured buyers can get it for as little as $25 a month.According to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-10-16/lilly-novo-fall-after-trump-touts-much-lower-ozempic-price">report</a>, Mehmet Oz, head of the Centers for Medicare and Medicaid Services, clarified that talks over the prices of weight loss drugs are still underway. “The GLP-1 category of drugs, which includes Ozempic, have not been negotiated yet,” Oz said.<a href="https://stocktwits.com/symbol/NVO">NVO stock</a> is down 37% year-to-date and 55% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-china-tariffs-not-sustainable/ch6sBXPR38Q">Trump Says China ‘Forced’ Him To Levy High Tariffs, But Thinks They Are ‘Not Sustainable’: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic

Greg Miley stated that he will join Novo Nordisk next month as the company’s senior vice president of corporate affairs.

Equity

AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin

AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin PR Newswire NORTH CHICAGO, Ill., Oct. 17, 2025...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Current Price	$229.00
Prev Close	$228.68
Open	$228.99
Dividend Yield	3.54%
50-Day Moving Average	$220.13
Beta	0.33
Avg. Volume	5.51M
PE Ratio	108.62

52-Week High	$244.81
52-Week Low	$163.81
Market Capitalization	$403.22B
EPS (Annual)	$2.39
Price to Book	-2,203.19
Revenue Per Employee	$1.02M
Enterprise Value/EBITDA	N/A

ABBV
Abbvie Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABBV News

ABBVAbbvie Inc